Summit Therapeutics to Present at the 43 rd Annual J.P. Morgan Healthcare Conference Miami, Florida, January 7, 2025 – Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that it will participate in and present at the 43 rd Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Monday, January 13,2025在下午3:00。Robert W. Duggan,董事长兼首席执行官,首席执行官兼总裁Maky Zanganeh博士将介绍公司概述和有关我们组织进度的最新信息,包括开发我们创新的双特异性抗体Ivonescimab。演示文稿将从我们的网站:www.smmttx.com现场直播。演示文稿后,将在我们的网站上找到演示文稿的存档版本。
主要关键词